Treatment Options for Parasomnias

被引:26
作者
Attarian, Hrayr [1 ,2 ]
机构
[1] Loyola Univ Chicago, Dept Neurol, Stritch Sch Med, Maywood, IL 60153 USA
[2] Loyola Univ Chicago, Dept Internal Med, Stritch Sch Med, Maywood, IL 60153 USA
关键词
Cognitive-behavioral treatment; Anticonvulsants; Benzodiazepines; Prazosin; Antidepressants; Anticholinergics; SLEEP BEHAVIOR DISORDER; POSTTRAUMATIC-STRESS-DISORDER; EXPLODING HEAD SYNDROME; TREATMENT-RESISTANT NIGHTMARES; REM-SLEEP; NOCTURNAL ENURESIS; DOUBLE-BLIND; POLYSOMNOGRAPHIC FEATURES; RECURRENT NIGHTMARES; ORAL DESMOPRESSIN;
D O I
10.1016/j.ncl.2010.03.025
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Parasomnias are undesirable physical or experiential events that occur in and around sleep. Treatments include reassurance in some cases, various forms of cognitive-behavioral therapy (CBT), and pharmacologic agents. Cognitive restructuring, imagery rehearsal, relaxation, hypnosis, desensitization, and anticipatory awakenings are some of the common CBT and nonpharmacologic interventions. Medications that are used belong to a wide variety of pharmacologic classes, such as alpha-blockers (prazosin), tricyclic antidepressants (imipramine and clomipramine), selective serotonin reuptake inhibitors, benzodiazepines (diazepam and clonazepam), anticonvulsants (topiramate and gabapentin), desmopressin acetate, and anticholinergic agents (oxybutynin and tolterodine). Data on efficacy are only available from randomized trials on CBT and prazosin for nightmares and on pharmacologic and alarm therapy for enuresis. No large-scale randomized trials are available to assess the efficacy of the other treatments, and most data come from anecdotal case reports, case series, or small open-label trials.
引用
收藏
页码:1089 / +
页数:19
相关论文
共 163 条
[1]
Aalbersberg C F, 2006, Tijdschr Psychiatr, V48, P487
[2]
ALLEN RM, 1983, J CLIN PSYCHIAT, V44, P106
[3]
[Anonymous], 2005, COCHRANE DB SYST REV
[4]
[Anonymous], 2005, International Classification of Sleep Disorders, V2nd
[5]
Combination Therapy With Desmopressin and an Anticholinergic Medication for Nonresponders to Desmopressin for Monosymptomatic Nocturnal Enuresis: A Randomized, Double-Blind, Placebo-Controlled Trial [J].
Austin, Paul F. ;
Ferguson, Genoa ;
Yan, Yan ;
Campigotto, Mary J. ;
Royer, Michele E. ;
Coplen, Douglas E. .
PEDIATRICS, 2008, 122 (05) :1027-1032
[6]
The impact of attention deficit hyperactivity disorders on Brainstem dysfunction in nocturnal enuresis [J].
Baeyens, Dieter ;
Roeyers, Herbert ;
Hoebeke, Piet ;
Antrop, Inge ;
Mauel, Rainer ;
Walle, Johan Vande .
JOURNAL OF UROLOGY, 2006, 176 (02) :744-748
[7]
Narcolepsy [J].
Claudio Bassetti .
Current Treatment Options in Neurology, 1999, 1 (4) :291-297
[8]
SLEEPWALKING - DIAGNOSIS AND TREATMENT THROUGH THE LIFE-CYCLE [J].
BERLIN, RM ;
QAYYUM, U .
PSYCHOSOMATICS, 1986, 27 (11) :755-760
[9]
BINDELGLAS PM, 1978, AM J PSYCHIAT, V135, P1549
[10]
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients [J].
Boeve, BF ;
Silber, MH ;
Ferman, TJ .
SLEEP MEDICINE, 2003, 4 (04) :281-284